Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Prichard

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
International Trends in Immunity|September 13, 2014
Anti-HSV activity of serpin antithrombin IIIDebra C Quenelle, Tracy L Hartman, Robert W Buckheit, et al.
Antiviral Chemistry & Chemotherapy|October 2, 2009
L-valine ester of cyclopropavir: a new antiviral prodrugZhimeng Wu, John C Drach, Mark N Prichard, et al.
Antiviral Research|October 6, 2018
A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesvirusesCaroll B Hartline, Kathy A Keith, Jessica Eagar, et al.
Virology Journal|March 7, 2008
Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidineMark N Prichard, Earl R Kern, Debra C Quenelle, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
Human herpesvirus 6 U69 kinase phosphorylates the methylenecyclopropane nucleosides cyclopropavir, MBX 2168, and MBX 1616 to their monophosphatesGloria Komazin-Meredith, Steven C Cardinale, John D Williams, et al.
Chemistry & Biodiversity|September 4, 2019
New 2-Oxoimidazolidine Derivatives: Design, Synthesis and Evaluation of Anti-BK Virus Activities in VitroYurii Kornii, Svitlana Chumachenko, Oleg Shablykin, et al.
Antiviral Research|June 25, 2008
Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigsDebra C Quenelle, Deborah J Collins, Terri L Rice, et al.
Journal of Medicinal Chemistry|July 11, 2006
Toward orthopoxvirus countermeasures: a novel heteromorphic nucleoside of unusual structureXuesen Fan, Xinying Zhang, Longhu Zhou, et al.
Virology Journal|March 31, 2006
Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID miceMark N Prichard, Debra C Quenelle, Deborah J Bidanset, et al.
Virology Journal|July 19, 2005
Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNAMark N Prichard, Heather Lawlor, Gregory M Duke, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
International Trends in Immunity|September 13, 2014
Anti-HSV activity of serpin antithrombin IIIDebra C Quenelle, Tracy L Hartman, Robert W Buckheit, et al.
Antiviral Chemistry & Chemotherapy|October 2, 2009
L-valine ester of cyclopropavir: a new antiviral prodrugZhimeng Wu, John C Drach, Mark N Prichard, et al.
Antiviral Research|October 6, 2018
A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesvirusesCaroll B Hartline, Kathy A Keith, Jessica Eagar, et al.
Virology Journal|March 7, 2008
Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidineMark N Prichard, Earl R Kern, Debra C Quenelle, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
Human herpesvirus 6 U69 kinase phosphorylates the methylenecyclopropane nucleosides cyclopropavir, MBX 2168, and MBX 1616 to their monophosphatesGloria Komazin-Meredith, Steven C Cardinale, John D Williams, et al.
Chemistry & Biodiversity|September 4, 2019
New 2-Oxoimidazolidine Derivatives: Design, Synthesis and Evaluation of Anti-BK Virus Activities in VitroYurii Kornii, Svitlana Chumachenko, Oleg Shablykin, et al.
Antiviral Research|June 25, 2008
Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigsDebra C Quenelle, Deborah J Collins, Terri L Rice, et al.
Journal of Medicinal Chemistry|July 11, 2006
Toward orthopoxvirus countermeasures: a novel heteromorphic nucleoside of unusual structureXuesen Fan, Xinying Zhang, Longhu Zhou, et al.
Virology Journal|March 31, 2006
Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID miceMark N Prichard, Debra C Quenelle, Deborah J Bidanset, et al.
Virology Journal|July 19, 2005
Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNAMark N Prichard, Heather Lawlor, Gregory M Duke, et al.
Pageof 8